Cargando…

Editorial: Protein–Protein Interactions: Drug Discovery for the Future

Detalles Bibliográficos
Autores principales:	Rapposelli, Simona, Gaudio, Eugenio, Bertozzi, Fabio, Gul, Sheraz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666435/ https://www.ncbi.nlm.nih.gov/pubmed/34912787 http://dx.doi.org/10.3389/fchem.2021.811190

Ejemplares similares

Editorial: Multi-Target-Directed Ligands (MTDL) as Challenging Research Tools in Drug Discovery: From Design to Pharmacological Evaluation
por: Alcaro, Stefano, et al.
Publicado: (2019)

Editorial: Computational Drug Discovery for Targeting of Protein-Protein Interfaces
por: Meli, Massimiliano, et al.
Publicado: (2021)

Editorial: Computational drug discovery for targeting of protein-protein interfaces—Volume II
por: Morra, Giulia, et al.
Publicado: (2023)

Query-guided protein–protein interaction inhibitor discovery
por: Celis, Sergio, et al.
Publicado: (2021)

Editorial: In silico Methods for Drug Design and Discovery
por: Brogi, Simone, et al.
Publicado: (2020)

Editorial: Advances in green synthesis for drug discovery
por: Allais, Florent, et al.
Publicado: (2023)

Hydrogen Sulfide: A Worthwhile Tool in the Design of New Multitarget Drugs
por: Sestito, Simona, et al.
Publicado: (2017)

Editorial: New insights into the mechanisms of resistance to anti-cancer drugs
por: Bertoni, Francesco, et al.
Publicado: (2022)

Epigenetic assays for chemical biology and drug discovery
por: Gul, Sheraz
Publicado: (2017)

Editorial: Computational Approaches in Drug Discovery and Precision Medicine
por: Huang, Zunnan, et al.
Publicado: (2021)

Editorial: Peptidomimetics: Synthetic Tools for Drug Discovery and Development
por: Del Gatto, Annarita, et al.
Publicado: (2021)

Editorial: Advances in drug discovery for anti-Alzheimer’s agents
por: Ismaili, Lhassane
Publicado: (2022)

Editorial: Current approaches in infectious disease drug discovery
por: Silva-Jr, Floriano P., et al.
Publicado: (2022)

Collecting data through high throughput in vitro early toxicity and off-target liability assays to rapidly identify limitations of novel thyromimetics
por: Runfola, Massimiliano, et al.
Publicado: (2020)

Editorial: Application of PROTACs as a Novel Strategy for Drug Discovery
por: Ibrahim, Hany S., et al.
Publicado: (2021)

Editorial: Cheminformatics Approaches in Drug Discovery for Neglected Tropical Diseases
por: Scotti, Luciana, et al.
Publicado: (2021)

G-Protein coupled receptors: structure and function in drug discovery
por: Odoemelam, Chiemela S., et al.
Publicado: (2020)

Key Considerations in Targeted Protein Degradation Drug Discovery and Development
por: Qin, Liena, et al.
Publicado: (2022)

Editorial: Computer-aided drug design: Drug discovery, computational modelling, and artificial intelligence
por: Ye, Fei, et al.
Publicado: (2022)

Discovery of a novel ligand that modulates the protein–protein interactions of the AAA+ superfamily oncoprotein reptin
por: Healy, Alan R., et al.
Publicado: (2015)

Discovery of lipid-mediated protein–protein interactions in living cells using metabolic labeling with photoactivatable clickable probes
por: Fedoryshchak, Roman O., et al.
Publicado: (2023)

In silico peptide-directed ligand design complements experimental peptide-directed binding for protein–protein interaction modulator discovery
por: Howell, Lesley Ann, et al.
Publicado: (2020)

Editorial: Discovery and Development of Drugs for Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis
por: Rivera, Gildardo, et al.
Publicado: (2021)

Arylnaphthalene lactone analogues: synthesis and development as excellent biological candidates for future drug discovery
por: Zhao, Chuang, et al.
Publicado: (2018)

Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery
por: Macalino, Stephani Joy Y., et al.
Publicado: (2018)

Drug discovery by targeting the protein–protein interactions involved in autophagy
por: Xiang, Honggang, et al.
Publicado: (2023)

Biospeciation of Potential Vanadium Drugs of Acetylacetonate in the Presence of Proteins
por: Sciortino, Giuseppe, et al.
Publicado: (2020)

QSAR Modeling for Multi-Target Drug Discovery: Designing Simultaneous Inhibitors of Proteins in Diverse Pathogenic Parasites
por: Kleandrova, Valeria V., et al.
Publicado: (2021)

Glycans in drug discovery
por: Valverde, Pablo, et al.
Publicado: (2019)

Mycobacterial drug discovery
por: Abrahams, Katherine A., et al.
Publicado: (2020)

Targeting protein-protein interaction interfaces in COVID-19 drug discovery
por: Chang, Chung-ke, et al.
Publicado: (2021)

Discovery of cisplatin-binding proteins by competitive cysteinome profiling
por: Wang, Xianghe, et al.
Publicado: (2023)

Targeting secondary protein complexes in drug discovery: studying the druggability and chemical biology of the HSP70/BAG1 complex
por: Evans, Lindsay E., et al.
Publicado: (2017)

Drug-Like Protein–Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology
por: Villoutreix, Bruno O, et al.
Publicado: (2014)

Editorial: BODIPYs and Their Derivatives: The Past, Present and Future
por: Lu, Hua, et al.
Publicado: (2020)

Editorial: Electrocatalysis Towards Carbon-Neutral Future
por: Jiang, Qiu, et al.
Publicado: (2023)

Editorial: Chemical Biology Tools for Peptide and Protein Research
por: Tsai, Yu-Hsuan, et al.
Publicado: (2022)

Modulators of protein–protein interactions as antimicrobial agents
por: Kahan, Rashi, et al.
Publicado: (2021)

Editorial: Discovery of Novel Molecules for Corrosion Protection Using Computational Chemistry
por: Obot, Ime B., et al.
Publicado: (2018)

Protein–RNA interactions: from mass spectrometry to drug discovery
por: Steinmetz, Benjamin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o34qukejtlqe1k1iuok655faad